XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Statements of Cash Flow - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash Flows from Operating Activities    
Net loss $ (14,733,780) $ (16,291,550)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 47,494 5,155
Gain/loss on disposal of fixed assets   34,549
Loss on extinguishment of debt 108,000  
Materials cost in connection with license activity   6,287
Issuance costs in connection with warrants issued in the November 2016 private investment in public entity 39,200  
Stock-based compensation 717,927 992,165
Amortization of debt issuance costs and debt discount 510,085 2,720,668
Change in fair value of warrants 43,200 501,617
Changes in assets and liabilities    
Accounts receivable - trade 50,904 (55,867)
Inventory (182,883) (31,842)
Prepaid expenses 21,389 (299,913)
Deferred offering costs (72,710)  
Other long-term assets   (122,163)
Due from parent (296,449) (19,780)
Deferred revenue (27,482) 228,134
Deferred rent 3,635 3,321
License fee payable (425,000) (1,200,000)
Accounts payable (28,336) (240,087)
Accrued expenses (188,912) (546,557)
Total cash used in operations (14,413,718) (14,315,863)
Cash Flows from Investing Activities    
Purchase of equipment (104,207) (23,300)
Sale of equipment   20,600
Change in restricted cash 2,488,707 (3,000,000)
Total cash provided by investing activities 2,384,500 (3,002,700)
Cash Flows from Financing Activities    
Proceeds from issuance of long-term debt   5,615,543
Repayment of long-term debt (2,488,706)  
Proceeds from issuance of redeemable convertible notes payable, net   1,250,000
Repayment of convertible notes payable   (100,000)
Repayment of notes payable   (1,000,000)
Proceeds from issuance of common stock in initial public offering, net of commissions and discounts   18,810,484
Deferred offering costs   (417,775)
Proceeds from issuance of common stock in follow-on secondary offering, net of commissions and discounts 5,000,000  
Proceeds from the exercise of common stock options   12,650
Total Cash Provided by Financing Activities 5,282,666 24,170,902
Net increase (decrease) in cash and cash equivalents (6,746,552) 6,852,339
Cash and cash equivalents, beginning of period 7,697,531 845,192
Cash and cash equivalents, end of period 950,979 7,697,531
Supplemental Schedule of Non-Cash Financing and Investing Activities    
Interest paid on long-term debt 478,665 173,250
Warrants issued in connection with convertible notes payable   47,479
Warrants issued in connection with notes payable 108,000  
Warrant, issued in conjunction with the initial public offering   400,400
Warrants issued in connection with private investment in public entity 756,001  
Accretion of redeemable convertible preferred stock   346,374
Abatement of license fee payable to Napo   250,000
Conversion of convertible preferred stock to common stock   7,651,288
Conversion of preferred stock warrant liability to common stock warrants   1,150,985
Conversion of convertible notes to common stock   $ 2,100,000
Secondary public offering    
Cash Flows from Financing Activities    
Deferred offering costs (869,898)  
Private Investment in Public Entities June 2016    
Cash Flows from Financing Activities    
Deferred offering costs (105,444)  
Proceeds from issuance of common stock in a private investment in public entities, net of commissions, discounts 2,676,746  
Private Investment in Public Entities October 2016    
Cash Flows from Financing Activities    
Proceeds from issuance of common stock in a private investment in public entities, net of commissions, discounts 150,000  
Private Investment in Public Entities November 2016    
Cash Flows from Financing Activities    
Deferred offering costs (80,033)  
Proceeds from issuance of common stock in a private investment in public entities, net of commissions, discounts $ 1,000,001